News Releases
Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
-
Mar 28, 2019- Companies Plan to Submit Biologics License Application Later This Year -
-
Mar 26, 2019- Investigational compound fezolinetant reduced frequency and severity of vasomotor symptoms in postmenopausal women -
-
Feb 20, 2019Joint Project Will Explore Enhancements to Patient Communication and Shared Decision-Making
-
Feb 11, 2019Data to be presented at the 2019 Genitourinary Cancers Symposium
-
Dec 14, 2018Acquisition adds clinical stage novel immuno-oncology programs to Astellas' oncology pipeline